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Abstract
Background: The novel coronavirus disease-2019 (COVID-19) has seriously affected the lives of millions of people
across the world. It has also heavily burdened healthcare professionals and the virus poses serious risks for their
personal and professional lives. Therefore, the present study examined the associations between fear of COVID-19
and workplace phobia among doctors in Pakistan during the COVID-19 pandemic.
Methods: An online survey was conducted among 421 doctors in Pakistan between April 10 and May 25, 2020.
The Workplace Phobia Scale (WPS) and the Fear of COVID-19 Scale (FCV-19S) were the main psychometric
instruments used in this study.
Results: There was a significant positive relationship between fear of COVID-19 and workplace panic anxiety and
workplace avoidance behavior. Significantly higher fear of COVID-19 was found among (i) females compared to
males, (ii) doctors with 5 years or less of work experience compared to those with more than 5 years, and (iii)
postgraduate trainees compared with other ranks. Two groups (doctors who were above 30 years old and
postgraduate trainees) were found to have higher levels of workplace phobia compared to their counterparts.
Doctors with severe levels of fear of COVID-19 had significantly higher levels of workplace panic anxiety and
workplace avoidance behavior.
Conclusions: Fear of COVID-19 was significantly associated with workplace phobia which may negatively affect
doctors’ performance. Therefore, important steps are needed to protect doctors’ health by providing sufficient
resources to allay their fears and anxieties which consequently help them in carrying out their frontline duties in
response to the COVID-19 pandemic.
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Background
The world is facing a unique challenge due to the emer-
gence of the novel coronavirus disease-2019 (COVID-
19) which has spread to a majority of countries world-
wide after the initial outbreak in Wuhan, China [1]. Ini-
tially, the response to the emergence of the virus was
relatively slow but after World Health Organization
(WHO) declared COVID-19 as a pandemic, most coun-
tries implemented specific policies such as home-
confinement, physical distancing, wearing of masks, fre-
quent washing of hands, and in extreme cases, nation-
wide lockdowns for preventing, treating, and containing
the spread of COVID-19 [2–4]. The disease has been as-
sociated with increased anxiety and fear among individ-
uals worldwide [5–7]. These responses are natural
considering the dangerous and unpredictable nature of
the virus [5–7].
Individuals infected with SARS-COV-2 show symp-
toms of fever, fatigue, dry cough, myalgia, and dyspnea
within first 2 weeks of contact [8]. By March 1, 2020, the
mortality rate of COVID-19 had reached 3.6% in China
and 1.5% in other countries [9]. According to a previous
study, among communicable diseases, lower respiratory
tract infections have the highest mortality globally [10].
The morbidity and mortality associated with COVID-19
during the pandemic have raised many problems in vari-
ous sectors. More specifically, it has been claimed that
mental health issues faced by medical staff are the least
recognized and under-addressed [11]. However, health-
care professionals’ mental health needs should be recog-
nized because they are not exempted from experiencing
them. According to a study conducted in Pakistan
among trainee doctors during the COVID-19 pandemic,
the prevalence of depressive symptoms, generalized anx-
iety disorder, and acute stress disorder were 26.4, 22.6,
and 4.4%, respectively [12]. Another study among doc-
tors during the pandemic from Lahore (Pakistan) re-
ported severe anxiety (7.2%) and depression (1%) among
a minority of those surveyed [13]. These Pakistani stud-
ies are important to because they are in the same coun-
try setting as the present study. Therefore, findings may
help with understanding the mental health challenges
among Pakistani doctors.
Previous studies on severe acute respiratory syndrome
(SARS) which has similarities to that of COVID-19 sug-
gested that healthcare workers (HCWs) and especially
doctors were specifically more prone to developing anx-
iety, depression, and stress [14]. This may be possible
based on the effect of either contracting the virus or the
work demands. This is because they are at a greater risk
of contracting the disease due to their direct involve-
ment in screening and treating SARS. Therefore, if an
HCW becomes infected with SARS-COV-2, the sudden
reversal of role from HCW to a patient adds to the levels
of fear, frustration, stigma, and adjustment issues [15].
On the other hand, the long duty shifts, increased work
hours, lack of personal protective equipment (PPE), and
lack of social support due to COVID-19 may affect their
mental health [16, 17]. As aforementioned, the lack of
appropriate PPE, heavy workloads [18], hostile environ-
ment and confrontation [19] may severely affect front-
line workers and lead to workplace phobia [20]. This
may explain why a worker might find it difficult to func-
tion effectively in the workplace and use avoidance be-
haviors which in turn may lead to high levels of anxiety
[21].
Workplace phobia has been a common problem in
primary healthcare [22] but with the current COVID-19
pandemic and frontline workers being directly affected,
workplace-related anxiety might be even more prevalent
[15]. However, the association between COVID-19 and
workplace phobia has been understudied and needs fur-
ther research since it is highly applicable in the current
pandemic [23].
The dangerous and unpredictable nature of COVID-
19 has instilled fears among doctors worldwide and es-
pecially among Pakistani doctors [19, 24]. As of April 25,
2021, there had been over 795,000 confirmed COVID-19
cases and over 17,000 deaths in Pakistan [25]. A previ-
ous study has shown that an infectious disease such as
COVID-19 with its high transmission rate and relatively
high mortality rate can lead to psychosocial problems in-
cluding stigmatization and bias on some level [26]. Fur-
thermore, doctors were also afraid of transmitting the
virus to their families as well as getting infected them-
selves. With no proven cure when the data were col-
lected, insufficient PPE, a lack of a nurturing and
accommodating environment, and a lack of support
from concerned health authorities, doctors may develop
anxieties, fear and/or aversion towards their duties [1,
18, 19, 24]. If the level of fear of COVID-19 were to ex-
ceed a specific limit, it might even affect doctor’s ration-
ality and decision-making ability and detrimentally
impact their work [27]. Therefore, there is the need for
further research to appropriately address the expectation
and fears of doctors in these unprecedented times.
The maintenance of healthy psychological wellbeing
among doctors is important to consider because they are
at the heart of the healthcare system and there is a
current lack of knowledge regarding how fear debilitates
their mental health capacity. Based on the aforemen-
tioned background literature, the present study exam-
ined the associations between fear of COVID-19 and
workplace phobia among doctors in Pakistan during the
COVID-19 pandemic. More specifically, this study ex-
amined the (i) relationship between fear of COVID-19
and workplace panic anxiety and workplace avoidance
behavior, (ii) between-group differences on fear of
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COVID-19 and workplace phobia, and (iii) differences
between the different severity levels of fear of COVID-
19 among doctors on their workplace phobia (i.e., work-
place panic anxiety and workplace avoidance behavior).
Through these results, we hope to shed light on Paki-
stani doctors’ mental health during COVID-19, so that




This cross-sectional study was conducted among doctors
(N = 421) dealing with COVID-19 patients in various
Pakistani hospitals from April 10 to May 25, 2020. Eth-
ical approval was obtained from the Institutional Review
Board (IRB) at the University of Sargodha (Pakistan). A
convenience sampling method was used to recruit par-
ticipants who were available and willing to participate in
the study by completing an online survey. To avoid sam-
pling errors, we took different steps. We requested ac-
cess to doctors working in COVID-19 wards and
isolation centers from the hospital administration. The
survey link was shared among the doctors dealing with
COVID-19 patients through WhatsApp and Facebook
groups of Pakistani doctors either directly or indirectly
through hospital administrators. Also, the selection cri-
teria (e.g., doctors treating COVID-19 patients) were
made very clear to the doctors as well as including sali-
ent information (i.e., demographic details, city, COVID-
19 ward or/and isolation center) in the survey about
their work. Informed consent was obtained from all par-
ticipants and they were assured that the information
they provide would be anonymous and confidential, and
only used for research purposes. All demographic infor-
mation about the participants can be found in Table 1.
Measures
The survey comprised three sections which are the (i)
socio-demographic characteristics, (ii) workplace phobia,
and (iii) fear of COVID-19. To assess workplace panic
anxiety and avoidance behavior, the Workplace Phobia
Scale was used. To assess fear of COVID-19, the Fear of
COVID-19 Scale (FCV-19S) was used. English versions
of the scales were used as it is the language used for
teaching medical professionals and also for writing clin-
ical notes in Pakistani hospitals. Also, the reliability of
the scales as used in the English language were tested
and all the scales showed acceptable psychometric prop-
erties. Details about the scales and their psychometric
properties are provided below.
Workplace phobia scale (WPS)
The WPS is a 13-item self-report scale that assesses
workplace panic anxiety and avoidance behaviors [28,
29]. The workplace panic anxiety subscale assesses phys-
ical panic-like reactions when individuals think about
the workplace while workplace avoidance behavior as-
sesses avoidance behavior that individuals show towards
the workplace. The items (e.g., “When thinking about my
Table 1 Demographic characteristics of the participants (N =
421)





≤ 30 years 271 64.4









House officers 51 12.1
Medical officers 125 29.7




















≤ 5 years 356 84.6
> 5 years 65 15.4
ENT Ear, Nose, Throat department; ICU Intensive Care Unit
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workplace, everything in my body is tense”) are rated on
a five-point scale from 0 (absolutely disagree) to 4 (abso-
lutely agree) with total scores ranging from 0 to 52.
Higher scores indicate higher levels of workplace phobia.
The reliability of the scale in the present study was ex-
cellent (Cronbach’s alpha = .938).
Fear of COVID-19 scale (FCV-19S)
The FCV-19S is a 7-item uni-dimensional self-report
scale that assesses the fear of COVID-19 [27]. The items
(e.g., “I am afraid of losing my life because of
coronavirus-19”) are rated on a five-point scale from 1
(strongly disagree) to 5 (strongly agree) with total scores
ranging from 7 to 35. The higher the score, the higher
the level of fear of COVID-19. The FCV-19S was classi-
fied into mild (score ≤ 14), moderate (score 14 to 28)
and severe (score ≥ 28) level based on a mean-standard
deviation formula similar to a previous study [30]. The
scale has been validated among Pakistanis [31]. The reli-
ability of the scale in the present study was excellent
(Cronbach’s alpha = .908).
Data analysis
SPSS software, version 21, was used for analyzing the
data. Means and percentages (where appropriate) for
each variable were calculated. Categorical variables were
analyzed using chi-square tests or Fisher’s exact test.
Continuous variables were analyzed using independent
t-tests, a one-way analysis of variance (ANOVA) for
between-group differences, and Pearson r for the rela-
tionship between the variables. A multivariate regression
analysis was then performed to identify factors associ-
ated with fear of COVID-19 and workplace phobia after
the assumptions were met. The basic assumptions of the
regression analysis were confirmed before conducting
the analysis. To guarantee the normality of data, skew-
ness and kurtosis were computed. The value of tolerance
and variance inflation factor showed that multicollinear-
ity was not a serious problem. After the confirmations,
the main analyses were carried out. Differences between
groups were considered to be significant when the p-
value was < .05.
Results
A total of 421 doctors (285 males, 67.7%; 136 females,
32.3%) with a mean age of 30.81 (SD = 6.22) years partic-
ipated in the study. Over half the participants were sin-
gle (56.3%). Most worked in the public sector (86.7%),
while the remainder worked in the private sector
(13.3%). The sample comprised 14.3% consultants, 12%
house officers, 29.7% medical officers, and 43.9% post-
graduate trainees. Most participants (84.6%) had five or
more years of experience in their field (Table 1).
The results of bivariate correlations in Table 2 showed
that there was a significant positive correlation between
fear of COVID-19 and workplace phobia in general (r =
.72, p < .01) and between the subscales; (ii) fear of
COVID-19 and workplace phobic panic anxiety (r = .74,
p < .01), and (iii) fear of COVID-19 and workplace avoi-
dant behavior (r = .64, p < .01).
Table 3, a regression analysis, shows that fear of
COVID-19 predicted workplace phobic anxiety among
doctors. Specifically, fear of COVID-19 significantly pre-
dicted workplace panic anxiety (standardized coefficient
[β] = .617, p < .001) and workplace avoidance behavior
(β = .546, p < .001). The value of ΔR2 of .380 and .296 in-
dicated that among doctors, fear predicted 38% variance
in workplace panic anxiety and 29.6% in workplace
avoidance behavior.
As shown in Table 4, female doctors (M = 22.18, SD =
6.9) had significantly higher fear of COVID-19 scores
(t(419) = − 2.531, p = .012) compared to male doctors
(M = 20.32, SD = 7.05). Furthermore, the results showed
that postgraduate trainee doctors (M = 22.75, SD = 6.66;
M = 23.15, SD = 13.20 for fear of COVID-19 and work-
place phobia respectively) had significantly higher fear of
COVID-19 (F(3, 417) = 8.285, p < .001) and workplace
phobia (F(3, 417) = 4.574, p = .004) as compared to house
officers (M = 20.02, SD = 6.72; M = 20.06, SD = 11.94),
medical officers (M = 18.96, SD = 6.93; M = 17.66, SD =
12.94), and consultants (M = 20.15, SD = 6.76; M = 20.72,
SD = 12.47). Finally, the results demonstrated that doc-
tors with less than 5 years’ experience (M = 21.29, SD =
7.00) had significantly higher fear of COVID-19
(t(419) = 2.481, p = 013) compared to those who had
more than 5 years’ experience (M = 18.94, SD = 7.09) in
their field. Experience as a trainee did not count as ex-
perience. Therefore, trainees were deemed as having no
years of experience in the present study.
Table 5 shows the differences between the different se-
verity levels of fear of COVID-19 among doctors in rela-
tion to their workplace phobia, and more specifically
workplace panic anxiety and workplace avoidance be-
havior. Findings indicated that doctors with a severe
level of fear of COVID-19 (M = 20.42, SD = 4.88; M =
14.12, SD = 4.55) showed significantly more workplace
panic anxiety (F(2, 418) = 130.12, p < .001) and avoidance
Table 2 Relationship between fear of COVID-19, anxiety and
work phobic anxiety
1 2 3 4
1 Fear of COVID-19 – .718** .736** .638**
2 Work phobic anxiety – .974** .955**
3 Work phobic panic anxiety – .865**
4 Work phobic avoidance anxiety –
**p < .01
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behavior (F(2, 418) = 92.42, p < .001) compared to those
having mild (M = 4.77, SD = 4.86; M = 3.67, SD = 3.97)
and moderate (M = 11.77, SD = 6.59; M = 7.75, SD = 5.15)
levels of fear of COVID-19.
Discussion
The present study examined the fear of COVID-19 and
workplace phobia among Pakistani doctors. More specif-
ically, it examined the (i) relationship between fear of
COVID-19 and workplace panic anxiety and workplace
avoidance behavior, (ii) between-group differences on
fear of COVID-19 and workplace phobia, and (iii) differ-
ences between the different severity levels of fear of
COVID-19 among doctors on their workplace phobia
(i.e., workplace panic anxiety and workplace avoidance
behavior). The findings showed that fear of COVID-19
was significantly associated with workplace panic anxiety
and avoidance behavior. That is, there was a significant
positive relationship between fear of COVID-19 and
workplace phobia as well as its subscales (workplace
panic anxiety and workplace avoidance behavior). All
the relationships had a large effect [32, 33]. This indi-
cates that the higher the doctor’s fear of COVID-19 then
the higher their workplace phobia (in general) and spe-
cifically workplace panic anxiety and workplace avoid-
ance behavior may also be. If these persist without
efficient coping or supportive system or environment,
may eventually affect their performance at work. Recent
studies have shown that fear of COVID-19 has impacted
negatively on individuals’ occupational lives [34–36].
During the COVID-19 pandemic, the mental health of
the professional healthcare workforce has noticeably
been affected.
Furthermore, the present study found that fear of
COVID-19 was a significant predictor of workplace
panic anxiety and workplace avoidance behavior among
doctors. Fear of COVID-19 accounted for 38% variance
in workplace panic anxiety and 29.6% in workplace
Table 3 Predicting role of fear of COVID-19 on workplace phobia among doctors
Workplace panic anxiety Workplace avoidance behavior
Variable ΔR2 β F ΔR2 β F
Fear of COVID-19 .380 .617*** 257.94*** .296 .546*** 177.56***
***p < .001
Table 4 Between-group comparison on fear of COVID-19 and workplace phobia
Fear of COVID-19 Work phobia
M (SD) p-value M (SD) p-value
Gender
Male 20.32 (7.05) .012* 20.27 (12.72) .230
Female 22.18 (6.95) 21.90 (13.66)
Age
≤ 30 years 20.70 (7.11) .385 19.71 (13.01) .034*
> 30 years 21.33 (6.99) 22.61 (12.94)
Marital status
Single/divorced 21.18 (7.25) .42 20.66 (13.41) .78
Married 20.62 (6.86) 21.01 (12.65)
Occupational sector
Government 20.91(6.99) .899 20.80 (12.97) .985
Private 21.04 (7.57) 20.77 (13.60)
Rank
Consultant 20.15 (6.76) .000*** 20.72 (12.47) .004**
House officers 20.02 (6.72) 20.06 (11.94)
Medical officers 18.96 (6.93) 17.66 (12.94)
Postgraduate trainees 22.75 (6.66) 23.15 (13.20)
Work experience
≤ 5 years 21.29 (7.00) .013* 20.96 (12.96) .557
> 5 years 18.94 (7.09) 19.91 (13.54)
*p < .05; **p < .01; ***p < .001. M and SD represent Mean and Standard Deviation respectively
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avoidance behavior among doctors. This indicates that
the fear of COVID-19 has the potential of negatively af-
fecting doctors work by specifically triggering phobic re-
actions (i.e., panic anxiety or avoidance behavior).
Therefore, it is important that sufficient resources and
enabling working conditions are provided for the doctors
to allay their fears of COVID-19 infection. Previous
studies have shown that fear of infection has a negative
psychological effect on health professionals who take
care of patients during epidemics which supports the
present study’s findings among doctors [5, 11–13].
It was further found that females, postgraduate
trainees, and those with five or less years of working ex-
perience had significantly higher levels of fear of
COVID-19 compared to their comparative counterparts.
This indicates that females, postgraduate trainees, and
those with five or less years of working experience, com-
pared to their comparative counterparts, may need extra
resources or support to allay their fear of COVID-19. A
possible explanation for this result may be that trainees
are new to the job, so they have not had as much expos-
ure to highly infectious diseases and the pandemic may
be more distressing for them hence, the higher levels of
fear of COVID-19 than their seniors. This also applied
to doctors with 5 years or less working experience.
These findings are consistent with those of Temsah
et al. [37] who reported that doctors were so over-
whelmed with the fear of COVID-19 that 15% of doctors
considered rescheduling or changing their duty so that
they could avoid COVID-19 patients. Similarly, Zhang
et al. [38] reported that during the COVID-19 pandemic,
female medical health workers experienced greater fear,
anxiety, depression, and obsessive-compulsive symptoms
than male doctors. Also, two groups (doctors who were
more than 30 years old and postgraduate trainees) had
significantly higher levels of workplace phobia compared
to their comparative counterparts suggesting that they
may have panic anxiety or avoid work compared to their
respective counterparts. Postgraduate trainees may need
special attention in the form of mentorship and counsel-
ing or psychotherapy to deal with their challenges
because they had higher levels of fear of COVID-19 and
then workplace phobia [39, 40]. Possible reasons for
doctors older than 30 years may be that they worry
about COVID-19 infection transmission from the work-
place to their families or job security after COVID-19 in-
fection [36, 41]. Nonetheless, hospital administration or
authorities must urgently refer such individuals to men-
tal health officers for further help.
In addition, it was found that there were differences
between the different severity levels of fear of COVID-
19 on workplace panic anxiety and avoidance behavior.
More specifically, doctors with a severe level of fear of
COVID-19 showed significantly more workplace panic
anxiety and avoidance behavior compared to those hav-
ing mild and moderate levels of fear of COVID-19. This
supports the earlier assertion that higher levels of fear of
COVID-19 are associated with workplace panic anxiety
and avoidance behavior and by extension, other mental
health challenges. The findings of the present study are
consistent with previous studies in Japan and Singapore
also reported a high level of fear and anxiety among
HCWs during the SARS-CoV outbreaks [42, 43] and
may also underlie the reasons for the higher mental
health challenges among Pakistani doctors [12, 13].
The present study has some specific limitations. First,
the convenience sampling method was used to recruit
the doctors and so may not represent the total Pakistani
doctor population. Future studies should carry out such
a survey on a nationally representative sample to con-
firm the findings of this study. Second, the present study
used a cross-sectional design which by nature can only
show the association between variables. Therefore, longi-
tudinal studies are needed to determine causality be-
tween the study’s variables. Therefore, researchers
should interpret the study’s findings with caution. Third,
the sample was not equally distributed with respect to
gender which may have affected the findings. Fourth,
this study merged single and divorced categories but
there may be differences in these two groups. Therefore,
future studies may want to separate these relationship
categories so as to examine their unique differences.
Table 5 Severity levels of fear of COVID-19 among doctors on their workplace phobia
Category N M SD F p LL UL Post Hoc
Workplace panic anxiety
Mild fear1 67 4.77 4.86 130.124 < .001 3.59 5.96 3 > 2 > 1
Moderate fear2 285 11.77 6.59 10.98 12.56
Severe fear3 85 20.42 4.88 19.37 21.48
Workplace avoidance behavior
Mild fear1 67 3.67 3.97 92.423 < .001 2.71 4.65 3 > 2 > 1
Moderate fear2 285 7.75 5.15 7.14 8.37
Severe fear3 85 14.12 4.55 13.13 15.09
N Number of participants, M Mean, SD Standard Deviation, LL Lower Limit, UL Upper Limit
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Finally, all the data were self-report and are therefore
subject to established methodological biases.
Healthcare workers can experience a serious risk of
COVID-19 exposure and consequently experience differ-
ent detrimental psychological conditions, lack of sleep,
low job satisfaction, fear, and work-related anxiety [36,
44]. The present study demonstrated significant associa-
tions between fear of COVID-19 and workplace phobia
(i.e., workplace panics anxiety and workplace avoidance
behavior). Therefore, it is important to provide doctors
with adequate personal protective equipment (PPE) and
a proper work-rotation schedule. The findings of the
present study have significant clinical and public health
implications. First, as the samples were doctors, the find-
ings could be helpful to clinicians, organizational psy-
chologists, and health administrators in understanding
how work-related pressures can negatively influence the
mental health of the HCW. The findings could also help
in the design of psychological interventions to deal with
such unprecedented pressures and its related psycho-
logical outcomes. As doctors and other healthcare
workers play an important and frontline role in the war
against COVID-19, it is necessary to ensure their good
mental health by encouraging them to express their
thoughts and by providing psychological help and talk
therapies. The findings of this study may also help
understand the needs of doctors in relation to proper
training and guidance regarding Standard operating pro-
cedure (SOPs), dealing with patients, and preventive
measures to deal with COVID-19. It is recommended
that adequate PPE and training should be provided to
the doctors in dealing with COVID-19 patients. Clear in-
structions regarding diagnosis and treatment protocol
will help relieve work pressure and increase occupational
satisfaction because it will help doctors in Pakistan to
understand the severity of the problem and how to cope
up with it.
Conclusion
The present study examined the associations between
fear of COVID-19 and workplace phobia among doctors
in Pakistan during the COVID-19 pandemic. It was
found that there were significant positive associations
between fear of COVID-19 and workplace phobia (i.e.,
workplace panic anxiety and workplace avoidance be-
havior). Also, females, postgraduate trainees, and those
with five or less years of working experience had signifi-
cantly higher levels of fear of COVID-19 compared to
their counterparts. Furthermore, two groups (doctors
who were more than 30 years old and postgraduate
trainees) had significantly higher levels of workplace
phobia compared to their counterparts. Additionally,
doctors with severe levels of fear of COVID-19 had
higher levels of workplace panic anxiety and workplace
avoidance behavior. These findings suggest that fear of
COVID-19 is an important factor that may negatively
affect doctors’ mental health and consequently their
work. Therefore, health administrators and authorities
may have to provide sufficient resources to allay the fear
of COVID-19 in addition to mentorship, an enabling
working environment, and requisite mental health
services.
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